[{"Assets_0_Q3_USD":201641000.0,"CommonStockSharesOutstanding_0_Q3_shares":79226083.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-49348000.0,"NetIncomeLoss_1_Q3_USD":-23635000.0,"NetIncomeLoss_3_Q3_USD":-78886000.0,"StockholdersEquity_0_Q3_USD":162086000.0,"Ticker":"IBRX","CIK":"1326110","name":"NANTKWEST, INC.","OfficialName":"ImmunityBio Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1985576569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]